Two Sigma Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75,598
| Closed | -$3.97M | – | 3956 |
|
|
2020
Q3 | $3.97M | Buy |
75,598
+1,834
| +2% | +$75.9K | 0.01% | 915 |
|
|
2020
Q2 | $2.45M | Sell |
73,764
-292,849
| -80% | -$9.32M | 0.01% | 995 |
|
|
2020
Q1 | $9.97M | Sell |
366,613
-264,462
| -42% | -$7.36M | 0.08% | 255 |
|
|
2019
Q4 | $12.5M | Buy |
631,075
+592,591
| +1,540% | +$9.48M | 0.04% | 529 |
|
|
2019
Q3 | $499K | Sell |
38,484
-91,578
| -70% | -$1.11M | ﹤0.01% | 2560 |
|
|
2019
Q2 | $1.62M | Buy |
130,062
+72,608
| +126% | +$964K | 0.01% | 1588 |
|
|
2019
Q1 | $835K | Sell |
57,454
-145,879
| -72% | -$1.86M | ﹤0.01% | 1934 |
|
|
2018
Q4 | $2.25M | Buy |
+203,333
| New | +$2.83M | 0.01% | 1183 |
|
|
2017
Q3 | – | Sell |
-72,660
| Closed | -$1.23M | – | 3365 |
|
|
2017
Q2 | $1.23M | Buy |
+72,660
| New | +$1.11M | ﹤0.01% | 1765 |
|
|
2017
Q1 | – | Sell |
-45,504
| Closed | -$685K | – | 3484 |
|
|
2016
Q4 | $685K | Buy |
+45,504
| New | +$601K | ﹤0.01% | 2286 |
|
|
2016
Q2 | – | Sell |
-75,975
| Closed | -$702K | – | 3382 |
|
|
2016
Q1 | $702K | Sell |
75,975
-130,656
| -63% | -$1.41M | ﹤0.01% | 1825 |
|
|
2015
Q4 | $3.07M | Buy |
206,631
+62,222
| +43% | +$1.04M | 0.01% | 870 |
|
|
2015
Q3 | $2.37M | Sell |
144,409
-127,115
| -47% | -$2.6M | 0.01% | 775 |
|
|
2015
Q2 | $6.19M | Buy |
271,524
+98,465
| +57% | +$1.96M | 0.03% | 622 |
|
|
2015
Q1 | $2.63M | Buy |
173,059
+57,795
| +50% | +$751K | 0.01% | 1025 |
|
|
2014
Q4 | $1.39M | Buy |
115,264
+84,964
| +280% | +$971K | 0.01% | 1215 |
|
|
2014
Q3 | $344K | Buy |
+30,300
| New | +$346K | ﹤0.01% | 1428 |
|
|
2013
Q3 | – | Sell |
-86,781
| Closed | -$1.31M | – | 2217 |
|
|
2013
Q2 | $1.31M | Buy |
+86,781
| New | +$1.15M | 0.01% | 1034 |
|
Two Sigma Investments's MNTA Position: Q4 2020 in Review
Two Sigma Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 75,598 shares — an estimated $3.97M sold.
Two Sigma Investments first reported a position in MNTA in Q2 2013 and held it in 18 quarters. The position peaked at $12.5M in Q4 2019. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Two Sigma Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Two Sigma Investments sold 75,598 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3.97M.
- Two Sigma Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
- Two Sigma Investments's Momenta Pharmaceuticals, Inc. position peaked at $12.5M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.